Table 2 Preoperative, perioperative and postoperative data
From: Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement
Variable | No PPM | PPM | P | |
|---|---|---|---|---|
(EOAI > 0.85 cm2/m2) n= 2613 | (EOAI ≤0.85 cm2/m2) n = 344 | |||
Age, years | 68±11 | 68±11 | 0.557 | |
Sex | ||||
Female | 965 (36.9) | 163 (47.4) | <0.001 | |
Endocarditis | 120 (4.6) | 15 (4.4) | 0.846 | |
Preoperative LV function | ||||
Severely impaired | (EF <30%) | 92 (3.5) | 11 (3.2) | 0.759 |
Hypertension | 1125 (43.1) | 166 (48.3) | 0.067 | |
Diabetes Mellitus | 413 (15.8) | 96 (27.9) | <0.001 | |
Body weight, kg | 77±13 | 84±15 | <0.001 | |
Height, cm | 170±9 | 170±9 | 0.807 | |
Body surface area (BSA), m2 | 1.89±0.19 | 1.95±0.18 | <0.001 | |
Body mass index (BMI), kg/m2 | 26.8±4.0 | 29.3±5.0 | <0.001 | |
Peripheral vascular disease (PVD) | 261 (10.0) | 41 (11.9) | 0.266 | |
Renal dysfunction | 147 (5.6) | 19 (5.5) | 0.938 | |
Chronic obstructive pulmonary disease (COPD) | 462 (17.7) | 72 (20.9) | 0.141 | |
Cerebrovascular accident (CVA) | 122 (4.7) | 236 (6.7) | 0.103 | |
Prosthetic valve diameter, mm | ||||
Median | 23 | 23 | ||
Prosthetic valve type | ||||
Mechanical | 1236 (47.3) | 240 (69.8) | <0.001 | |
Concomitant coronary artery bypass grafting (CABG) | 1121 (42.9) | 135 (39.2) | 0.197 | |
Cardiopulmonary bypass (CPB) time, min | 93±37 | 99±43 | 0.022 | |
Aortic cross-clamp time, min | 68±26 | 71±30 | 0.077 | |
Effective orifice area (EOA), cm2 | 2.14±0.44 | 1.54±0.17 | <0.001 | |
Indexed effective orifice area (EOAI), cm2/m2 | 1.14±0.21 | 0.79±0.06 | <0.001 | |
Additive EuroSCORE | 6±3 | 6±3 | 0.095 | |
Logistic EuroSCORE | 7.66± 8.14 | 8.64±9.29 | 0.146 | |
Previous cardiac surgery | 226 (8.6) | 59 (17.2) | <0.001 | |
Mean follow-up, years | 5.6±3.7 | 6.3±4.0 | <0.001 | |
Mortality ≤30 days | 100 (3.8) | 23 (6.7) | 0.013 | |